Two Thymus Peptides Helped Mouse Hearts Regenerate After a Heart Attack

Delivering thymosin β4 and prothymosin α together to injured mouse hearts promoted heart muscle cell division and reduced cardiac dysfunction after a heart attack.

Gladka, Monika M et al.·Cardiovascular research·2023·
RPEP-069092023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Using single-cell RNA sequencing, researchers identified a distinct gene expression profile in the rare cardiomyocytes that enter the cell cycle after myocardial infarction in mice. They found increased DNA synthesis (EdU incorporation) in cardiomyocytes 3 days post-infarction, confirmed by clonal expansion in the border zone of infarcted tissue using multi-color lineage tracing.

Among the enriched genes in proliferating cardiomyocytes, a combination of thymosin β4 (TMSB4) and prothymosin α (PTMA) proved most effective. When delivered therapeutically to the heart wall after ischemic injury, this two-peptide cocktail promoted cardiomyocyte proliferation and attenuated cardiac dysfunction. The study demonstrates that both activating cell division and creating a permissive microenvironment are necessary for cardiac regeneration.

Key Numbers

How They Did This

Researchers induced myocardial infarction (heart attacks) in mice and used EdU incorporation and multi-color lineage tracing to identify and track proliferating cardiomyocytes. Single-cell RNA sequencing of cardiomyocytes at 3 days post-injury revealed the transcriptional profile of cycling cells. Candidate genes were tested by combinatorial overexpression in neonatal rat cardiomyocytes and postnatal day 12 mice. The most promising gene combinations were then therapeutically delivered into the myocardial wall of adult mice after ischemic injury to assess regenerative effects.

Why This Research Matters

Heart disease is the leading cause of death worldwide, and a heart attack permanently destroys heart muscle because adult cardiomyocytes barely divide. Finding ways to restart heart cell division has been a holy grail of cardiac research. This study is significant because it identifies a specific peptide combination — thymosin β4 and prothymosin α — that promotes heart regeneration in a mammalian model, moving beyond single-factor approaches and showing that creating a supportive environment is as important as triggering cell division itself.

The Bigger Picture

Thymosin β4 has long been studied for its roles in wound healing, inflammation, and tissue repair, but this study adds a new dimension: it can work with prothymosin α to promote heart muscle regeneration. The finding that both cell-autonomous (proliferation signals) and microenvironmental factors are needed for cardiac regeneration could reshape how researchers approach heart repair strategies. It also highlights the value of single-cell genomics in identifying rare cell populations and their therapeutic potential.

What This Study Doesn't Tell Us

This is a preclinical study in mice, and mouse hearts have somewhat greater regenerative capacity than human hearts. The gene delivery approach used (direct myocardial wall injection) would need significant adaptation for clinical use. Long-term outcomes and safety were not assessed. The exact mechanisms by which TMSB4 and PTMA create a permissive environment for proliferation require further investigation. Results in neonatal rat cardiomyocytes and P12 mice may not fully predict adult human responses.

Questions This Raises

  • ?Could thymosin β4 and prothymosin α be delivered non-invasively (e.g., as peptides rather than gene therapy) to achieve similar cardiac regeneration?
  • ?Does this peptide combination promote regeneration in larger animal models with hearts more similar to humans?
  • ?What is the mechanism by which PTMA creates a permissive environment — does it modulate inflammation, extracellular matrix, or immune cell activity in the border zone?

Trust & Context

Key Stat:
2-peptide cocktail Thymosin β4 + prothymosin α together created a permissive environment for cardiomyocyte proliferation and reduced cardiac dysfunction
Evidence Grade:
This is a well-designed preclinical study using multiple complementary techniques (single-cell sequencing, lineage tracing, gene delivery) in a mouse model. While the evidence is strong for the animal model, no human data exists for this specific therapeutic approach.
Study Age:
Published in 2023, this is a recent study reflecting the current state of cardiac regeneration research and single-cell genomics technology.
Original Title:
Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.
Published In:
Cardiovascular research, 119(3), 802-812 (2023)
Database ID:
RPEP-06909

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why can't the heart heal itself after a heart attack?

Adult heart muscle cells (cardiomyocytes) have largely exited the cell cycle — they've stopped dividing. When a heart attack kills heart cells, the body replaces them with scar tissue instead of new muscle. This study found that a tiny number of heart cells do try to divide after injury, and identified the peptides that could amplify this process.

What are thymosin β4 and prothymosin α?

Both are small peptides originally studied for their roles in the immune system (the thymus gland). Thymosin β4 is well known for promoting cell migration, wound healing, and reducing inflammation. Prothymosin α is involved in cell proliferation and immune regulation. This study shows that together, they create conditions that allow heart muscle cells to divide and repair damage after a heart attack in mice.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06909·https://rethinkpeptides.com/research/RPEP-06909

APA

Gladka, Monika M; Johansen, Anne Katrine Z; van Kampen, Sebastiaan J; Peters, Marijn M C; Molenaar, Bas; Versteeg, Danielle; Kooijman, Lieneke; Zentilin, Lorena; Giacca, Mauro; van Rooij, Eva. (2023). Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.. Cardiovascular research, 119(3), 802-812. https://doi.org/10.1093/cvr/cvac155

MLA

Gladka, Monika M, et al. "Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice.." Cardiovascular research, 2023. https://doi.org/10.1093/cvr/cvac155

RethinkPeptides

RethinkPeptides Research Database. "Thymosin β4 and prothymosin α promote cardiac regeneration p..." RPEP-06909. Retrieved from https://rethinkpeptides.com/research/gladka-2023-thymosin-4-and-prothymosin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.